NYSTATIN- nystatin oral suspension suspension
TriRx Huntsville Pharmaceutical Services, LLC
----------
NYSTATIN
nystatin oral suspension suspension |
Product Information |
Product Type | HUMAN PRESCRIPTION DRUG | Item Code (Source) | NDC: 80432-003 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
NYSTATIN (UNII: BDF1O1C72E) (NYSTATIN - UNII:BDF1O1C72E) | NYSTATIN | 100000 [USP'U] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 80432-003-08 | 60 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product | 09/01/2019 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA065148 | 09/01/2019 | 09/30/2023 |
|
Labeler - TriRx Huntsville Pharmaceutical Services, LLC
(117090286)
|
Establishment |
Name | Address | ID/FEI | Business Operations |
TriRx Huntsville Pharmaceutical Services, LLC | | 117090286 | manufacture(80432-003) |
TriRx